Literature DB >> 10660400

Outbreaks of enterovirus 71 infection.

S AbuBakar, Y F Chan, S K Lam.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 10660400     DOI： 10.1056/NEJM200002033420513

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

1.  The compatibility of inactivated-Enterovirus 71 vaccination with Coxsackievirus A16 and Poliovirus immunizations in humans and animals.

Authors:  Qunying Mao; Yiping Wang; Jie Shao; Zhifang Ying; Fan Gao; Xin Yao; Changgui Li; Qiang Ye; Miao Xu; Rongcheng Li; Fengcai Zhu; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015-02-25       Impact factor: 3.452

2.  Mutation in enterovirus 71 capsid protein VP1 confers resistance to the inhibitory effects of pyridyl imidazolidinone.

Authors:  Shin-Ru Shih; Mun-Chung Tsai; Sung-Nien Tseng; Kuo-Fang Won; Kak-Shan Shia; Wen-Tai Li; Jyh-Haur Chern; Guang-Wu Chen; Chung-Chi Lee; Yen-Chun Lee; Kuan-Chang Peng; Yu-Sheng Chao
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

3.  Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71.

Authors:  Tzu-Chun Chen; Hwan-You Chang; Pei-Fen Lin; Jyh-Haur Chern; John Tsu-An Hsu; Chu-Yi Chang; Shin-Ru Shih
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

4.  Phylogenetic evidence for inter-typic recombination in the emergence of human enterovirus 71 subgenotypes.

Authors:  Chan Yoke-Fun; Sazaly AbuBakar
Journal:  BMC Microbiol       Date:  2006-08-30       Impact factor: 3.605

5.  Development and evaluation of a pseudovirus-luciferase assay for rapid and quantitative detection of neutralizing antibodies against enterovirus 71.

Authors:  Xing Wu; Qunying Mao; Xin Yao; Pan Chen; Xiangmei Chen; Jie Shao; Fan Gao; Xiang Yu; Fengcai Zhu; Rongcheng Li; Wenhui Li; Zhenglun Liang; Junzhi Wang; Fengmin Lu
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

6.  The cross-neutralizing activity of enterovirus 71 subgenotype c4 vaccines in healthy chinese infants and children.

Authors:  Qunying Mao; Tong Cheng; Fengcai Zhu; Jingxin Li; Yiping Wang; Yanping Li; Fan Gao; Lisheng Yang; Xin Yao; Jie Shao; Ningshao Xia; Zhenglun Liang; Junzhi Wang
Journal:  PLoS One       Date:  2013-11-19       Impact factor: 3.240

Review 7.  Methodological choices for the clinical development of medical devices.

Authors:  Alain Bernard; Michel Vaneau; Isabelle Fournel; Hubert Galmiche; Patrice Nony; Jean Michel Dubernard
Journal:  Med Devices (Auckl)       Date:  2014-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.